Canopy Growth Corporation (CGC) Research

Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.

Market snapshot

Symbol
CGC
Price
$0.97
Day change
+2.49%
Market cap
$247.2M
P/E ratio
-1.78x
52-week range
0.844-2.38
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months
Analyst price target
$14.47

Recent news

  • Canopy Growth revenue climbs 14% in Q4

    Canopy Growth Corporation (TSX:WEED, NYSE:CGC) reported a narrower quarterly loss and double-digit full-year revenue growth on Monday, as the Canadian cannabis company cited the acquisition of MTL Cannabis and a strategic recapitalization as key drivers of its turnaround effort. The company posted an adjusted loss per share of $0.29 for its fiscal fourth quarter, missing analyst estimates, though the result represented a 71% improvement from the $1.01 loss in the same period a year earlier.

  • Canopy Growth revenue climbs 14% in Q4

    Canopy Growth Corporation (TSX:WEED, NYSE:CGC) reported a narrower quarterly loss and double-digit full-year revenue growth on Monday, as the Canadian...

Peer companies

  • Aurora Cannabis Inc. (ACB)
  • Aclaris Therapeutics, Inc. (ACRS)
  • BioAge Labs, Inc. (BIOA)
  • Cabaletta Bio, Inc. (CABA)
  • Definitive Healthcare Corp. (DH)
  • Ironwood Pharmaceuticals, Inc. (IRWD)
  • Lifecore Biomedical, Inc. (LFCR)
  • Lyell Immunopharma, Inc. (LYEL)

Recent insider activity

  • Yanofsky Theresa — S-Sale (10373 shares) on 2026-03-31
  • ATKINS M SHAN — S-Sale (2074 shares) on 2026-03-31
  • BAYERN JOSEPH — S-Sale (2658 shares) on 2026-03-31
  • Lazzarato David Angelo — S-Sale (15624 shares) on 2026-03-31
  • Mongeau Luc — S-Sale (9376 shares) on 2026-02-11

Open Canopy Growth Corporation (CGC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.